Skip to content
PubMed This is a summary of 83 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 83 referenced papers

Top Authors

Lewis C. Cantley
Beth Israel Deaconess Medical Center
Christian C. Dibble
Beth Israel Deaconess Medical Center
Qiaobing Xu
Tufts University
David M. Sabatini
Czech Academy of Sciences
Brendan D. Manning
Harvard University
Min Qiu
Fudan University
Daniel J. Siegwart
Southwestern Medical Center
Francis X. McCormack
University of Cincinnati
Elizabeth P. Henske
Fox Chase Cancer Center
Nishant Gupta
University of Cincinnati

Top Institutions

Ranked by publications Top 10 institutions
02

Chinese Academy of Medical Sciences & Peking Union Medical College

Beijing, China

92 papers
03

The University of Texas Southwestern Medical Center

Dallas, United States

34 papers
10

References

References (83)
  1. 1

    Regulation of mTORC1 by PI3K signaling.

    Dibble CC, Cantley LC

    Trends in cell biology 2015; (25(9)):545-55.

    PMID: 26159692
  2. 2

    Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations.

    Freitas CS, Baldi BG, Araújo MS, et al.

    Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 2015; (41(3)):275-80.

    PMID: 26176526
  3. 3

    Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis.

    Ussavarungsi K, Hu X, Scott JP, et al.

    Respiratory medicine 2015; (109(10)):1354-9.

    PMID: 26321137
  4. 4

    Detection of low-prevalence somatic TSC2 mutations in sporadic pulmonary lymphangioleiomyomatosis tissues by deep sequencing.

    Fujita A, Ando K, Kobayashi E, et al.

    Human genetics 2016; (135(1)):61-8 doi:10.1007/s00439-015-1611-0.

    PMID: 26563443
  5. 5

    SUCCESSFUL TREATMENT OF PULMONARY AND LYMPHATIC MANIFESTATIONS OF LYMPHANGIOLEIOMYOMATOSIS WITH SIROLIMUS.

    Hecimovic A, Jakopovic M, Pavlisa G, et al.

    Lymphology 2015; (48(2)):97-102.

    PMID: 26714374
  6. 6

    Lung Transplantation for Lymphangioleiomyomatosis in Japan.

    Ando K, Okada Y, Akiba M, et al.

    PloS one 2016; (11(1)):e0146749 doi:10.1371/journal.pone.0146749.

    PMID: 26771878
  7. 7

    A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis.

    Argula RG, Kokosi M, Lo P, et al.

    Annals of the American Thoracic Society 2016; (13(3)):342-9 doi:10.1513/AnnalsATS.201509-631OC.

    PMID: 26799509
  8. 8

    Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial.

    Araujo MS, Baldi BG, Freitas CS, et al.

    The European respiratory journal 2016; (47(5)):1452-60 doi:10.1183/13993003.01683-2015.

    PMID: 26917604
  9. 9

    Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation.

    Zaki KS, Aryan Z, Mehta AC, et al.

    World journal of transplantation 2016; (6(1)):249-54 doi:10.5500/wjt.v6.i1.249.

    PMID: 27011924
  10. 10

    Tuberous Sclerosis Complex Associated with Vascular Anomalies or Overgrowth.

    Jenkins D, McCuaig C, Drolet BA, et al.

    Pediatric dermatology 2016; (33(5)):536-42 doi:10.1111/pde.12946.

    PMID: 27470532
  11. 11

    Efficacy and Safety of Long-Term Sirolimus Therapy for Asian Patients with Lymphangioleiomyomatosis.

    Takada T, Mikami A, Kitamura N, et al.

    Annals of the American Thoracic Society 2016; (13(11)):1912-1922 doi:10.1513/AnnalsATS.201605-335OC.

    PMID: 27513278
  12. 12

    Coexistence of pulmonary lymphangioleiomyomatosis and pulmonary angiomyolipoma.

    Sun X, Feng R, Zhang Y, et al.

    BMC pulmonary medicine 2016; (16(1)):120 doi:10.1186/s12890-016-0286-1.

    PMID: 27527652
  13. 13

    Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.

    McCormack FX, Gupta N, Finlay GR, et al.

    American journal of respiratory and critical care medicine 2016; (194(6)):748-61 doi:10.1164/rccm.201607-1384ST.

    PMID: 27628078
  14. 14

    [Pulmonary lymphangioleimyomatosis : review and case report].

    Excoffier S, Guinand O, Rochat T

    Revue medicale suisse 2016; (12(527)):1390-1393.

    PMID: 28671794
  15. 15

    Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline.

    Gupta N, Finlay GA, Kotloff RM, et al.

    American journal of respiratory and critical care medicine 2017; (196(10)):1337-1348 doi:10.1164/rccm.201709-1965ST.

    PMID: 29140122
  16. 16

    Cystic Lung Disease in Genetic Syndromes with Deficient Tumor Suppressor Gene Function.

    Daccord C, Nicod LP, Lazor R

    Respiration; international review of thoracic diseases 2017; (94(6)):467-485 doi:10.1159/000485106.

    PMID: 29169151
  17. 17

    Emerging biomarkers of lymphangioleiomyomatosis.

    Nijmeh J, El-Chemaly S, Henske EP

    Expert review of respiratory medicine 2018; (12(2)):95-102 doi:10.1080/17476348.2018.1409622.

    PMID: 29171770
  18. 18

    Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study.

    Zhan Y, Shen L, Xu W, et al.

    Orphanet journal of rare diseases 2018; (13(1)):34 doi:10.1186/s13023-018-0775-9.

    PMID: 29458386
  19. 19

    Single lung transplantation for lymphangioleiomyomatosis: a single-center experience in Japan.

    Oishi H, Watanabe T, Matsuda Y, et al.

    Surgery today 2018; (48(10)):944-950 doi:10.1007/s00595-018-1678-z.

    PMID: 29808303
  20. 20

    Smoking-Related Diffuse Cystic Lung Disease.

    Gupta N, Colby TV, Meyer CA, et al.

    Chest 2018; (154(2)):e31-e35 doi:10.1016/j.chest.2018.02.027.

    PMID: 30080520
  21. 21

    Efficacy of sirolimus for the prevention of recurrent pneumothorax in patients with lymphangioleiomyomatosis: a case series.

    Zhou L, Ouyang R, Luo H, et al.

    Orphanet journal of rare diseases 2018; (13(1)):168 doi:10.1186/s13023-018-0915-2.

    PMID: 30241551
  22. 22

    Correlation between the native lung volume change and postoperative pulmonary function after single lung transplantation for lymphangioleiomyomatosis: Evaluation of lung volume by three-dimensional computed tomography volumetry.

    Suzuki H, Oishi H, Noda M, et al.

    PloS one 2019; (14(2)):e0210975 doi:10.1371/journal.pone.0210975.

    PMID: 30742625
  23. 23

    Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis.

    Hirose M, Matsumuro A, Arai T, et al.

    PloS one 2019; (14(2)):e0212776 doi:10.1371/journal.pone.0212776.

    PMID: 30818375
  24. 24

    Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis.

    Gupta N, Lee HS, Young LR, et al.

    The European respiratory journal 2019; (53(4)) doi:10.1183/13993003.02066-2018.

    PMID: 30846465
  25. 25

    Difficult diagnosis and rare morphology of lymphangioleiomyomatosis with giant cysts.

    Welter S, Thrull P, Westhoff M, et al.

    Respiratory medicine case reports 2019; (28()):100873 doi:10.1016/j.rmcr.2019.100873.

    PMID: 31249775
  26. 26

    Low-dose sirolimus in retroperitoneal lymphangioleiomyomas.

    Ussavarungsi K, Laroia AT, Burger CD

    Lung India : official organ of Indian Chest Society 2019; (36(4)):349-352 doi:10.4103/lungindia.lungindia_433_18.

    PMID: 31290423
  27. 27

    Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis.

    Hu S, Wu X, Xu W, et al.

    Orphanet journal of rare diseases 2019; (14(1)):206 doi:10.1186/s13023-019-1178-2.

    PMID: 31429781
  28. 28

    Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study.

    Kim C, Do KH, Cha J, et al.

    European radiology 2020; (30(2)):735-743 doi:10.1007/s00330-019-06412-4.

    PMID: 31471750
  29. 29

    The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis.

    Wang Q, Luo M, Xiang B, et al.

    Respiratory research 2020; (21(1)):55 doi:10.1186/s12931-020-1316-3.

    PMID: 32059669
  30. 30

    Lymphangioleiomyomatosis.

    Xu KF, Xu W, Liu S, et al.

    Seminars in respiratory and critical care medicine 2020; (41(2)):256-268 doi:10.1055/s-0040-1702195.

    PMID: 32279296
  31. 31

    Refractory chylous effusions in lymphangioleiomyomatosis patient post lung transplant.

    Jacob S, Ali M, El-Sayed Ahmed MM, et al.

    SAGE open medical case reports 2020; (8()):2050313X20921332 doi:10.1177/2050313X20921332.

    PMID: 32477564
  32. 32

    Molecular logic of mTORC1 signalling as a metabolic rheostat.

    Valvezan AJ, Manning BD

    Nature metabolism 2019; (1(3)):321-333 doi:10.1038/s42255-019-0038-7.

    PMID: 32694720
  33. 33

    Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts.

    Taveira-DaSilva AM, Johnson SR, Julien-Williams P, et al.

    Thorax 2020; (75(10)):904-907 doi:10.1136/thoraxjnl-2020-214987.

    PMID: 32788260
  34. 34

    A woman with dyspnea and recurrent pneumothorax: when dyspnea is not asthma.

    Chidharla A, Sehring M, Ascencio MA, Chittivelu S

    Journal of community hospital internal medicine perspectives 2020; (10(4)):334-337 doi:10.1080/20009666.2020.1771125.

    PMID: 32850091
  35. 35

    Effect of non-uniform cyst distribution in lymphangioleiomyomatosis on pulmonary function: a cross-sectional study.

    Hasani AM, Matthew B, Goljamali M, et al.

    The European respiratory journal 2021; (57(3)) doi:10.1183/13993003.03769-2020.

    PMID: 33419888
  36. 36

    Structural insights into TSC complex assembly and GAP activity on Rheb.

    Yang H, Yu Z, Chen X, et al.

    Nature communications 2021; (12(1)):339 doi:10.1038/s41467-020-20522-4.

    PMID: 33436626
  37. 37

    Methacholine reactivity in lymphangioleiomyomatosis is inversely related to FEV1 and VEGF-D.

    Cassandro R, Elia D, Caminati A, et al.

    The European respiratory journal 2021; (57(6)) doi:10.1183/13993003.04270-2020.

    PMID: 33653809
  38. 38

    CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis.

    Evans JF, Obraztsova K, Lin SM, Krymskaya VP

    International journal of molecular sciences 2021; (22(5)) doi:10.3390/ijms22052233.

    PMID: 33668092
  39. 39

    Chylous Ascites as a Presentation of Lymphangioleiomyomatosis.

    McLain JH, Khadarian K, Shojaie L, et al.

    ACG case reports journal 2021; (8(3)):e00517 doi:10.14309/crj.0000000000000517.

    PMID: 33681402
  40. 40

    Pregnancy after the diagnosis of lymphangioleiomyomatosis (LAM).

    Shen L, Xu W, Gao J, et al.

    Orphanet journal of rare diseases 2021; (16(1)):133 doi:10.1186/s13023-021-01776-7.

    PMID: 33731151
  41. 41

    Uncommon radiologic computed tomography appearances of the chest in patients with lymphangioleiomyomatosis.

    Sekimoto Y, Suzuki K, Okura M, et al.

    Scientific reports 2021; (11(1)):7170 doi:10.1038/s41598-021-85999-5.

    PMID: 33785773
  42. 42

    Retroperitoneal Lympathic Malformations as First Presentation of Lymphangioleiomyomatosis.

    Lenfant C, Dragean CA

    Journal of the Belgian Society of Radiology 2021; (105(1)):32 doi:10.5334/jbsr.2468.

    PMID: 34131625
  43. 43

    Tuberous sclerosis complex for the pulmonologist.

    Rebaine Y, Nasser M, Girerd B, et al.

    European respiratory review : an official journal of the European Respiratory Society 2021; (30(161)) doi:10.1183/16000617.0348-2020.

    PMID: 34348978
  44. 44

    Lung Diseases Unique to Women.

    Criner RN, Al-Abcha A, Lambert AA, Han MK

    Clinics in chest medicine 2021; (42(3)):507-516 doi:10.1016/j.ccm.2021.04.014.

    PMID: 34353455
  45. 45

    Cathepsin K is Superior to HMB45 for the Diagnosis of Pulmonary Lymphangioleiomyomatosis.

    Rolim I, Makupson M, Lovrenski A, Farver C

    Applied immunohistochemistry & molecular morphology : AIMM 2022; (30(2)):108-112 doi:10.1097/PAI.0000000000000968.

    PMID: 34433182
  46. 46

    COVID-19 in a patient with sporadic lymphangioleiomyomatosis awaiting lung transplantation.

    Noda Y, Shiroyama T, Amiya S, et al.

    Respiratory medicine case reports 2021; (34()):101505 doi:10.1016/j.rmcr.2021.101505.

    PMID: 34493971
  47. 47

    The TSC Complex-mTORC1 Axis: From Lysosomes to Stress Granules and Back.

    Rehbein U, Prentzell MT, Cadena Sandoval M, et al.

    Frontiers in cell and developmental biology 2021; (9()):751892 doi:10.3389/fcell.2021.751892.

    PMID: 34778262
  48. 48

    A rare lung disease diagnosed by CT in a young pregnant woman.

    Persad S, Dowlath N, Prasad M, Harry V

    Clinical case reports 2021; (9(11)):e05071 doi:10.1002/ccr3.5071.

    PMID: 34795900
  49. 49

    [Anxiety about Health of Patients Suffering from Epilepsy].

    Roth-Rawald J, Friedrich J, Straub HB, Weck F

    Psychotherapie, Psychosomatik, medizinische Psychologie 2022; (72(6)):243-249 doi:10.1055/a-1686-9789.

    PMID: 34911105
  50. 50

    Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis.

    Qiu M, Tang Y, Chen J, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2022; (119(8)) doi:10.1073/pnas.2116271119.

    PMID: 35173043
  51. 51

    Pulmonary lymphangioleiomyomatosis (LAM): A literature overview and case report.

    Cong CV, Anh TT, Ly TT, Duc NM

    Radiology case reports 2022; (17(5)):1646-1655 doi:10.1016/j.radcr.2022.02.075.

    PMID: 35330669
  52. 52

    Long-term clinical course and progression of lymphangioleiomyomatosis in a single lung transplant referral centre in Korea.

    Chang S, Choi JS, Leem AY, et al.

    Scientific reports 2022; (12(1)):8260 doi:10.1038/s41598-022-12314-1.

    PMID: 35585116
  53. 53

    Sirolimus reduces the risk of pneumothorax recurrence in patients with lymphangioleiomyomatosis: a historical prospective self-controlled study.

    Cheng C, Xu W, Wang Y, et al.

    Orphanet journal of rare diseases 2022; (17(1)):257 doi:10.1186/s13023-022-02418-2.

    PMID: 35804431
  54. 54

    Two most common diagnoses among myriads of cystic lung diseases.

    Swol J, Würflein D, Böhm J, Ficker JH

    Hippokratia 2021; (25(2)):83-86.

    PMID: 35937517
  55. 55

    Prophylactic renal artery embolization before pregnancy in patients with lymphangioleiomyomatosis and renal angiomyolipoma.

    Toei H, Zhang X, Seyama K, et al.

    The Journal of international medical research 2022; (50(9)):3000605221123897 doi:10.1177/03000605221123897.

    PMID: 36124884
  56. 56

    Lung transplantation for lymphangioleiomyomatosis.

    Warrior K, Dilling DF

    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2023; (42(1)):40-52 doi:10.1016/j.healun.2022.09.021.

    PMID: 36334961
  57. 57

    Clinical features and outcomes of male patients with lymphangioleiomyomatosis: A review.

    Zhang H, Hu Z, Wang S, et al.

    Medicine 2022; (101(52)):e32492 doi:10.1097/MD.0000000000032492.

    PMID: 36596036
  58. 58

    Predicting Individualized Lung Disease Progression in Treatment-Naive Patients With Lymphangioleiomyomatosis.

    Palipana AK, Gecili E, Song S, et al.

    Chest 2023; (163(6)):1458-1470 doi:10.1016/j.chest.2022.12.027.

    PMID: 36610667
  59. 59

    Determinants of Progression and Mortality in Lymphangioleiomyomatosis.

    Xu W, Yang C, Cheng C, et al.

    Chest 2023; (164(1)):137-148 doi:10.1016/j.chest.2023.02.026.

    PMID: 36801466
  60. 60

    mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion.

    Liu HJ, Du H, Khabibullin D, et al.

    Nature communications 2023; (14(1)):1214 doi:10.1038/s41467-023-36881-7.

    PMID: 36869048
  61. 61

    Scanxiety among Adults with Cancer: A Scoping Review to Guide Research and Interventions.

    Derry-Vick HM, Heathcote LC, Glesby N, et al.

    Cancers 2023; (15(5)) doi:10.3390/cancers15051381.

    PMID: 36900174
  62. 62

    Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meet.

    Gibbons E, Minor BMN, Hammes SR

    Endocrine-related cancer 2023; (30(9)).

    PMID: 37410387
  63. 63

    Survey of maternal anxiety and perceptions towards foetal MRI and pre-scan education.

    Plunkett S, Dobeli K, Prior M, Tusek X

    Journal of medical radiation sciences 2024; (71(1)):10-20 doi:10.1002/jmrs.725.

    PMID: 37724764
  64. 64

    Lymphangioleiomyomatosis with Tuberous Sclerosis Complex-A Case Study.

    Marciniak A, Nawrocka-Rutkowska J, Brodowska A, et al.

    Journal of personalized medicine 2023; (13(11)) doi:10.3390/jpm13111598.

    PMID: 38003913
  65. 65

    A case report of lymphangioleiomyomatosis with retroperitoneal masses in pregnancy.

    Zhu Y, Wang C, Ding J, et al.

    Frontiers in medicine 2023; (10()):1313503 doi:10.3389/fmed.2023.1313503.

    PMID: 38188337
  66. 66

    Complications of lymphangioleiomyomatosis in pregnancy: a case report and review of the literature.

    Wang-Koehler E, Kern-Goldberger AR, Srinivas SK

    AJOG global reports 2024; (4(1)):100309 doi:10.1016/j.xagr.2024.100309.

    PMID: 38327672
  67. 67

    Case report: If it is not asthma-think of lymphangioleiomyomatosis in younger female patients.

    Kirkeby MH, Bendstrup E, Rose HK

    Frontiers in medicine 2024; (11()):1328471 doi:10.3389/fmed.2024.1328471.

    PMID: 38410750
  68. 68

    Clinical, tomographic and functional comparison of sporadic and tuberous sclerosis complex-associated forms of lymphangioleiomyomatosis: a retrospective cohort study.

    Oliveira MR, Wanderley M, Freitas CSG, et al.

    ERJ open research 2024; (10(2)) doi:10.1183/23120541.00759-2023.

    PMID: 38444661
  69. 69

    Epidemiology of patients with lymphangioleiomyomatosis: A descriptive study using the national database of health insurance claims and specific health checkups of Japan.

    Kimura Y, Jo T, Hashimoto Y, et al.

    Respiratory investigation 2024; (62(3)):494-502 doi:10.1016/j.resinv.2024.03.010.

    PMID: 38583226
  70. 70

    Giant Renal Angiomyolipomas and Pulmonary Lymphangioleiomyomatosis: Follow-up Report after More than a Decade.

    Nasir K, Ahmad A

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2023; (34(6)):671-675 doi:10.4103/sjkdt.sjkdt_324_21.

    PMID: 38725217
  71. 71

    Stepwise Incremental Dose Schedule of Sirolimus Is Successfully Tolerated by a Patient With Lymphangioleiomyomatosis Who Was Initially Allergic to mTOR Inhibitors.

    Seyama K, Komiyama E, Tsuchihashi H, et al.

    Cureus 2024; (16(4)):e58805 doi:10.7759/cureus.58805.

    PMID: 38784348
  72. 72

    Clinical and Functional Outcomes Associated with Quality of Life in Patients with Lymphangioleiomyomatosis: A Cross-Sectional Study.

    Queiroz DS, da Silva CCBM, Oliveira MR, et al.

    Lung 2024; (202(6)):757-765 doi:10.1007/s00408-024-00751-w.

    PMID: 39402376
  73. 73

    Immature Smooth Muscle Infiltration in Sporadic Lymphangioleiomyomatosis: A Case Study.

    Stearns C, Muirhead D, Rosell B

    South Dakota medicine : the journal of the South Dakota State Medical Association 2024; (77(11)):511-515.

    PMID: 39820446
  74. 74

    Lymphangioleiomyomatosis and Pregnancy-Do We Have All the Answers for a Woman Who Desires to Conceive?-Literature Review.

    Constantin AA, Gaburici AD, Malaescu AN, et al.

    Cancers 2025; (17(2)) doi:10.3390/cancers17020323.

    PMID: 39858105
  75. 75

    Brazilian Thoracic Association recommendations for the management of lymphangioleiomyomatosis.

    Baldi BG, Feitosa PHR, Rubin AS, et al.

    Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 2025; (51(1)):e20240378 doi:10.36416/1806-3756/e20240378.

    PMID: 39936727
  76. 76

    Application of sirolimus in an infant presenting with a life-threatening lymphatic malformation of the head and neck: a case report.

    Yu S, Guo X

    Frontiers in pediatrics 2025; (13()):1587330 doi:10.3389/fped.2025.1587330.

    PMID: 40342900
  77. 77

    White Adipocyte Stem Cell Expansion Through Infant Formula Feeding: New Insights into Epigenetic Programming Explaining the Early Protein Hypothesis of Obesity.

    Melnik BC, Weiskirchen R, John SM, et al.

    International journal of molecular sciences 2025; (26(10)) doi:10.3390/ijms26104493.

    PMID: 40429638
  78. 78

    Sporadic Lymphangioleiomyomatosis in a 35-Year-Old Female Patient: A Rare Cause of Spontaneous Pneumothorax.

    Rodenko PN, Elefteratos J, Rodenko EL, et al.

    Cureus 2025; (17(7)):e87346 doi:10.7759/cureus.87346.

    PMID: 40761985
  79. 79

    Prevalence, severity, and modifiable predictors of scanxiety in patients undergoing routine oncologic imaging: a prospective longitudinal study.

    Shah MS, Memon JA, Malik U, et al.

    Clinical imaging 2025; (128()):110634 doi:10.1016/j.clinimag.2025.110634.

    PMID: 41077027
  80. 80

    Benefits of different characteristics of pulmonary rehabilitation programs in patients with interstitial lung disease: a systematic review and meta-analysis.

    Chen Q, Qiu Y, Xu M, Dong L

    Annals of medicine 2025; (57(1)):2566868 doi:10.1080/07853890.2025.2566868.

    PMID: 41140098
  81. 81

    Diagnostic Value of Serum VEGF-D in Lymphangioleiomyomatosis: Results of the First Prospective Study in the Russian Federation.

    Makarova M, Baimakanova G, Belevskiy A, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(4)) doi:10.3390/diagnostics16040533.

    PMID: 41750682
  82. 82

    TSC2, cathepsin K, and β-catenin as immunohistochemical markers for lymphangioleiomyomatosis.

    Alfayez A, Belanger E, Cheung S, Churg A

    Human pathology 2026; (174()):106142 doi:10.1016/j.humpath.2026.106142.

    PMID: 42102978
  83. 83

    Ten-year follow-up of monozygotic twin sisters with TSC-LAM: A rare case report.

    Fan L, Elia D, Cassandro R, Harari SA

    Respiratory medicine case reports 2026; (62()):102436 doi:10.1016/j.rmcr.2026.102436.

    PMID: 42211577